CUREVAC RNA PRINTER GMBH

RNA PRINTER

Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules;Chemical preparations for medical use; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment of infectious diseases, allergies, autoimmune disorder and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparations; Health care preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements;Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes;Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders;Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules;

RNA TO GO

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements;Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes;Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders;RNA;Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules;

SEQUENCEFOUR

Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules; Mobile production station of biological macromolecules;Machines; Machines for use in chemical or biopharmaceutical industry; Bioreactors; Apparatus for chemical or biological analysis and/or synthesis; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industry roboters;Chemical preparations for medical use, in particular biological macromolecules; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations; Health care preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines;SEQUENCE FOUR;Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes;Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Vaccination;Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules; Custom synthesis of chemical compounds, in particular biological macromolecules;

THE RNA PRINTER

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements;Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes;Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders;RNA;Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules;